Biotech

Companies & Industries News

Biotech Companies & Industries Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 06.07.2022.

#biotech
#BioSpace
#NYU
#regenerativemedicine
#otology
#genetics
#metagenomics
#bioinformatics
#microbiome
#NBTintheNews

@biospace shared
On Jul 1, 2022
A team of researchers at @nyuniversity (NYU) has successfully created synthetic versions of the Hox genes that control biological development in humans, according to an article published in Science. #NYU #BioSpace https://t.co/h9oBF7sElA
Open
NYU Researchers Create Synthetic Versions of Hox Genes

NYU Researchers Create Synthetic Versions of Hox Genes

A team of researchers at New York University has successfully created synthetic versions of the Hox genes that control biological development in humans.

@pharmaphorum shared
On Jul 5, 2022
UK #biotech Mogrify gets partnership with Japanese drugmaker Astellas on a #regenerativemedicine approach to sensorineural hearing loss #otology https://t.co/30m0REB0d1
Open
Astellas teams up with UK biotech Mogrify on hearing loss project

Astellas teams up with UK biotech Mogrify on hearing loss project

Cell therapy specialist Mogrify has struck a deal with Japanese drugmaker Astellas to look at ways to deploy

@Labiotech_eu shared
On Jul 5, 2022
Microbial diversity is all around us. Until now, it was difficult to comprehensively examine and analyze it. Enter #metagenomics, a field that is radically changing microbial analyses. 🧫 #bioinformatics #microbiome #biotech #genetics @computomics https://t.co/sT189E3Hbm
Open
Metagenomics: unlocking the secrets of microbial communities

Metagenomics: unlocking the secrets of microbial communities

Metagenomics can now help researchers unlock the secrets of microbial communities and answer exciting research questions. 

@pharmaphorum shared
On Jul 4, 2022
After side-lining its lead coeliac disease drug, @9metersbio reports phase 2 results with vurolenatide in short bowel syndrome, with phase 3 due to start before year end #biotech $NMTR https://t.co/0BH00q7owV
Open
After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome

After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome

Two weeks after reporting disappointing results for its lead coeliac disease therapy, 9 Meters Biopharma will draw some

@GENbio shared
On Jul 1, 2022
Potential Therapeutic Treatment for Androgenetic Alopecia Work led by researchers at the University of California, Irvine has uncovered a signaling molecule called SCUBE3 that stimulates hair growth and may offer a therapeutic treatment. Learn more: https://t.co/66QJHCgiSy https://t.co/GlHQWWsFW7
Open
Potential Therapeutic Treatment for Androgenetic Alopecia

Potential Therapeutic Treatment for Androgenetic Alopecia

The signaling molecule SCUBE3 has been identified as possible therapeutic treatment for androgenetic alopecia.

@NatureBiotech shared
On Jul 5, 2022
@PlantEnergyBiol @SMS_UWA @UWAresearch @PerkinsComms @ry_lister Synthetic gene circuits for precise reprogramming of plants #NBTintheNews via @uwanews https://t.co/wT7xzOzepQ
Open
Synthetic gene circuits for precise reprogramming of plants

Synthetic gene circuits for precise reprogramming of plants

Researchers from The University of Western Australia are building synthetic gene circuits to control and customise where, when, and under what environmental conditions a gene is turned on ...

@Labroots shared
On Jul 4, 2022
Scientists Urge Study of Bacteria in Melting Glaciers | There is incredible potential, both good and bad, in the thousands of bacterial genes identified in this research. https://t.co/feFrLW6f2G https://t.co/0jtDRSI7Ly
Open
Scientists Urge Study of Bacteria in Melting Glaciers

Scientists Urge Study of Bacteria in Melting Glaciers

Globally, temperatures are on the rise. Between the years of 2009 and 2019, glaciers around the world lost an average of about 275 gigatonnes (Gt) of ice every | Genetics And Genomics

@GENbio shared
On Jul 5, 2022
Viral Vaccine Harnesses Protein-Degradation Machinery A new strategy for generating live-attenuated viral vaccines uses PROTAC technology to prompt host cells to degrade viral proteins. Read more: https://t.co/BU7ZgsFob7 https://t.co/iqfEYxsvsg
Open
Viral Vaccine Harnesses Protein-Degradation Machinery

Viral Vaccine Harnesses Protein-Degradation Machinery

A new strategy for generating live-attenuated viral vaccines uses PROTAC technology to prompt host cells to degrade viral proteins. The strategy was shown to elicit strong immune responses ...